1H-Indole-1-pentanoicacid, 2-carboxy-2,3-dihydro-a,g-dimethyl-d-oxo-, a-ethyl ester, (aR,gR,2S)- (82924-03-6)

Identification
Name:	1H-Indole-1-pentanoicacid, 2-carboxy-2,3-dihydro-a,g-dimethyl-d-oxo-, a-ethyl ester, (aR,gR,2S)-
Synonyms:	1H-Indole-1-pentanoicacid, 2-carboxy-2,3-dihydro-a,g-dimethyl-d-oxo-, a-ethyl ester, [2S-[1(aS,gS),2R*]]-; CGS 13945; Pentopril
CAS:	82924-03-6
Molecular Formula:	C18H23 N O5
Molecular Weight:	0
InChI:	InChI=1/C18H23NO5/c1-4-24-18(23)12(3)9-11(2)16(20)19-14-8-6-5-7-13(14)10-15(19)17(21)22/h5-8,11-12,15H,4,9-10H2,1-3H3,(H,21,22)/t11-,12-,15+/m1/s1
Molecular Structure:
Properties
Flash Point:	293.8°C
Boiling Point:	562.1°C at 760 mmHg
Density:	1.221g/cm³
Refractive index:	1.549
Flash Point:	293.8°C
Safety Data

Other Product

1-Pyrrolidinepentanoicacid, 2-carboxy-g-methyl-d-oxo-, (gR,2S)-
1H-Indole-1-pentanoicacid, 2-carboxy-d-oxo-a-[[(phenylmethoxy)carbonyl]amino]-2,3-dihydro-,[S-(R*,S*)]- (9CI)
1H-Indole-1-pentanoicacid, a-amino-2,3-dihydro-5-(2-methoxy-2-oxoethyl)-7-nitro-d-oxo-, (aS)-
Cyclohexanehexanamide, g-hydroxy-N-[1-(hydroxymethyl)-2-oxo-2-[(2-pyridinylmethyl)amino]ethyl]-a-(1-methylethyl)-d-[[3-methyl-2-[[(1-naphthalenyloxy)acetyl]amino]-1-oxobutyl]amino]-,[aS-[N(R*),aR*,gR*,dR*(R*)]]- (9CI)
1H-Indole-1-pentanoicacid, 2-carboxyoctahydro-d-oxo-a-[[(phenylmethoxy)carbonyl]amino]-,[2S-[1(S*),2a,3ab,7ab]]- (9CI)
Oxacyclodotetraconta-4,22,26,30,40-pentaene-2-pentanoicacid, g,6,8,10,12,14,16,18,20,21,24,28,34,36-tetradecahydroxy-d,11,13,23,25,29,35,37,41-nonamethyl-42-oxo-,(dR,gR,2S,4E,6S,8S,10R,11S,12R,13S,14S,16S,18S,20R,21S,22E,24R,25S,26E,28S,29S,30E,34S,35S,36R,37S,40E)-
Cyclohexanehexanamide, g-hydroxy-N-[2-hydroxy-1-[[(2-pyridinylmethyl)amino]carbonyl]propyl]-a-(1-methylethyl)-d-[[3-methyl-2-[[(1-naphthalenyloxy)acetyl]amino]-1-oxobutyl]amino]-,[aS-[N(1R*,2S*),aR*,gR*,dR*(R*)]]- (9CI)
4H-Pyran-2-hexanoicacid, b-hydroxy-a,g,e,3,5,6-hexamethyl-d,4-dioxo-, (2S)-2-methyl-1-[(1S)-1-methyl-2-oxobutyl]-3-oxopentyl ester, (aS,bS,gR,eR)-
Cyclohexanehexanamide, g-hydroxy-a-(1-methylethyl)-N-[2-methyl-1-[[(2-pyridinylmethyl)amino]carbonyl]butyl]-d-[[2-[[(1-naphthalenyloxy)acetyl]amino]-1-oxo-3-(phosphonooxy)propyl]amino]-,dipotassium salt, [aS-[N(1R*,2R*),aR*,gR*,dR*(R*)]]- (9CI)
Cyclohexanehexanamide, g-hydroxy-a-(1-methylethyl)-N-[2-methyl-1-[[(2-pyridinylmethyl)amino]carbonyl]butyl]-d-[[2-[[(1-naphthalenyloxy)acetyl]amino]-1-oxo-3-(phosphonooxy)butyl]amino]-,dipotassium salt, [aS-[N(1R*,2R*),aR*,gR*,dR*(2R*,3S*)]]- (9CI)
4H-Pyran-2-hexanoicacid, 6-ethyl-b-hydroxy-a,g,e,3,5-pentamethyl-d,4-dioxo-, (2S)-2-methyl-1-[(1S)-1-methyl-2-oxobutyl]-3-oxopentyl ester, (aS,bS,gR,eR)-
1H-Azepine-1-pentanoicacid, g-(benzoylamino)hexahydro-d-oxo-
1H-Thieno[3,4-d]imidazole-4-pentanoicacid, hexahydro-2-oxo-, ethyl ester, (3aS,4S,6aR)-
1-Pyrrolidinebutanoicacid, 2-carboxy-g-oxo-,(2S)-
1H-Indole-1-pentanoic acid, 2-carboxy-2,3-dihydro-alpha,gamma-dimethyl -delta-oxo-, (2S-(1(alphaS*,gammaS*),2R*))-
1H-Thieno[3,4-d]imidazole-4-pentanoicacid, hexahydro-2-oxo-, 2,5-dioxo-3-sulfo-1-pyrrolidinyl ester, (3aS,4S,6aR)-
1H-Indole-1-pentanoicacid, a-amino-2,3-dihydro-4-methoxy-7-nitro-d-oxo-, (aS)-
Oxacyclodotetraconta-4,22,26,30,40-pentaene-2-pentanoicacid, g,6,8,10,12,14,16,18,20,24,28,34,36-tridecahydroxy-21-(a-D-mannopyranosyloxy)-d,11,13,23,25,29,35,37,41-nonamethyl-42-oxo-,(gR,dR,2S,4E,6S,8S,10R,11S,12R,13S,14S,16S,18S,20R,21S,22E,24R,25S,26E,28S,29S,30E,34S,35S,36R,37S,40E)-(9CI)
4H-Pyran-2-hexanoicacid, 6-ethyl-b-hydroxy-a,g,e,3,5-pentamethyl-d,4-dioxo-,(1S,2S,3S,4S,6S)-3-ethyl-3-hydroxy-2,4,6-trimethyl-5-oxocyclohexyl ester, (aS,bS,gR,eR)- (9CI)
Pentanoicacid, 2-(methoxyimino)-4-oxo-, ethyl ester